Skip to content

A single-arm study to evaluate the efficacy of modified microneedle radiofrequency in axillary osmidrosis

A single-arm study to evaluate the efficacy of modified microneedle radiofrequency in axillary osmidrosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113477
Enrollment
Unknown
Registered
2025-11-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillary osmidrosis

Interventions

Experimental Group:Peninsula Healthcare fractional radiofrequency(Power (W): 12-20W
Pulse width (ms): 200-400 (recommended 300ms)
once)

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Clinical manifestations associated with bilateral axillary odor, specific axillary odor, and excessive axillary sweatingclinical manifestations related to underarm odor, special odor in the armpits, and excessive sweating in the armpits; 2.Bilateral underarm odor;

Exclusion criteria

Exclusion criteria: 1. People with skin tumors or active skin diseases; 2. Those suffering from severe heart, lung, liver, kidney-related diseases, hemorrhagic diseases or infectious diseases; 3. There are skin lesions, ulcers, etc. in the treated area; 4. Pregnant women; 5. People with keloid-prone constitution; 6. Those wearing pacemakers, vascular stents or metal implants;

Design outcomes

Primary

MeasureTime frame
Park and Shin;

Secondary

MeasureTime frame
Lodine starch experiment;Patient satisfaction;Chief Complaint Pain Scale (VAS) : The degree of pain is evaluated and recorded immediately after treatment;Specific adverse events;Oodor -5 subscale score;

Countries

China

Contacts

Public ContactRong Xiao

The Second Xiangya Hospital of Central South University

xiaorong65@aliyun.com+86 731 8529 5260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026